Proof of Concept for Lenvatinib and Everolimus Prior to Cytoreductive Nephrectomy in Eligible Patients With Locally Advanced and Metastatic Renal Cell Carcinoma (RCC)
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 07 May 2018
At a glance
- Drugs Everolimus (Primary) ; Lenvatinib (Primary)
- Indications Renal cell carcinoma
- Focus Proof of concept; Therapeutic Use
- 27 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 Jul 2018.
- 08 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Mar 2018.
- 01 Nov 2017 New trial record